ITT Inc (NYSE: ITT) has reported E.P.S. of $1.56 for its fourth fiscal quarter (ending December 31) versus $1.13 for the same period a year ago — an increase of 38%. E.P.S. were $6.34 for […]
Huntington Ingalls Industries In (NYSE: HII) has reported E.P.S. of $3.15 for its fourth fiscal quarter (ending December 31) versus $6.90 for the same period a year ago — a decline of -54%. For the […]
On 2/6/25, Hologic Inc (NASDAQ: HOLX) stock suffered a major decline of -10.1%, closing at $65.45. Moreover, trading volume in this decline was exceptionally high at 327% of normal. The stock has performed in line […]
Haemonetics Corp (NYSE: HAE) has reported earnings for its third fiscal quarter (ending December 31) of $0.75 versus $0.62 for the same period a year ago — an increase of 21%. For the latest four […]
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock suffered a major decline of -15.1% on 2/6/25. The shares closed at $6.62. Moreover, trading volume in this decline was unusually high at 197% of normal. The stock has […]
Digi International Inc (NASDAQ: DGII) stock enjoyed a major increase of 17.3% on 2/6/25. The shares closed at $35.68. Moreover, trading volume in this advance was exceptionally high at 406% of normal. The stock has […]
For its fourth fiscal quarter (ending December 31), Darling Ingredients Inc (NYSE: DAR) has reported a 21% increase in E.P.S. from $0.53 a year ago to $0.64 in the current quarter. E.P.S. were $1.75 for […]
Clearfield Inc (NASDAQ: CLFD) has reported a loss for its first fiscal quarter (ending December 31) of $-0.13 versus a loss $-0.35 for the same period a year ago — a decline of -63%. For […]
CNO Financial Group Inc (NYSE: CNO) has reported E.P.S. of $1.62 for its fourth fiscal quarter (ending December 31) versus $0.33 for the same period a year ago — an increase of 391%. For the […]
For its fourth fiscal quarter (ending December 31), Bristol-Myers Squibb Co (NYSE: BMY) has reported a -95% decline in E.P.S. from $0.87 a year ago to $0.04 in the current quarter. E.P.S. were $-4.41 for […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research